IL6 and infection: Infection with combinations of LLO-Lm-OVA and ActA-Lm-OVA led to the dose-dependent reduction of serum IFN-γ, IL-12p70, IL-6 and MCP-1 relative to ActA-Lm-OVA alone (Figure 4A).